Compare NCST to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 1.76 |
|---|---|
| Trade Time: | Dec 18 |
| Change: | 0.00 (0.00%) |
| Prev Close: | 1.76 |
| Open: | 1.76 |
| Bid: | 1.00 x 10000 |
| Ask: | N/A |
| 1y Target Est: | 5.00 |
| Day's Range: | 1.76 - 1.77 |
|---|---|
| 52wk Range: | 0.25 - 1.79 |
| Volume: | 8,000 |
| Avg Vol (3m): | 50,270.3 |
| Market Cap: | 32.25M |
| P/E (ttm): | N/A |
| EPS (ttm): | 0.00 |
| Div & Yield: | N/A (N/A) |
| Thu, Dec 17 | Cashing In on Obamacareat Motley Fool |
| Wed, Nov 25 | NUCRYST PHARMACEUTICALS CORP. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Fri, Nov 20 | NUCRYST Announces Special Meeting of ShareholdersPR Newswire |
| Thu, Nov 19 | NUCRYST PHARMACEUTICALS CORP. FinancialsEDGAR Online Financials |
| Tue, Nov 17 | NUCRYST PHARMACEUTICALS CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements anEDGAR Online |
| Mon, Nov 16 | NUCRYST PHARMACEUTICALS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online |
| Fri, Nov 13 | NUCRYST announces 2009 third quarter financial resultsPR Newswire |
| Wed, Nov 11 | Smith & Nephew to buy Nucryst assets for $21 mlnat MarketWatch |
| Tue, Nov 10 | NUCRYST Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with WestaimPR Newswire |
| Mon, Nov 2 | CEO Interview: Quick-Med Technologies, Inc. - J. Ladd GreenoWall Street Transcript |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.